Extension of Time to File SOU

FULGENURA

JOHNSON & JOHNSON

Request for Extension of Time to File a Statement of Use

PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number

Request for Extension of Time to File a Statement of Use
(15 U.S.C. Section 1051(d))


The table below presents the data as entered.

Input Field
Entered
SERIAL NUMBER 88079662
LAW OFFICE ASSIGNED LAW OFFICE 109
MARK SECTION
MARK FULGENURA (see, http://uspto.report/TM/88079662/mark.png)
STANDARD CHARACTERS YES
USPTO-GENERATED IMAGE YES
LITERAL ELEMENT FULGENURA
OWNER SECTION (current)
NAME JOHNSON & JOHNSON
MAILING ADDRESS One Johnson & Johnson Plaza
CITY New Brunswick
STATE New Jersey
ZIP/POSTAL CODE 08933
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
OWNER SECTION (proposed)
NAME JOHNSON & JOHNSON
MAILING ADDRESS One Johnson & Johnson Plaza
CITY New Brunswick
STATE New Jersey
ZIP/POSTAL CODE 08933
STATE/COUNTRY/REGION/JURISDICTION/U.S. TERRITORY United States
EMAIL XXXX
CORRESPONDENCE INFORMATION (current)
NAME Matthew Pater
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmus@its.jnj.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) kmanchen@its.jnj.com
CORRESPONDENCE INFORMATION (proposed)
NAME Matthew Pater
PRIMARY EMAIL ADDRESS FOR CORRESPONDENCE tmus@its.jnj.com
SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES) kmanchen@its.jnj.com
DOCKET/REFERENCE NUMBER T36599US2
GOODS AND/OR SERVICES SECTION
INTERNATIONAL CLASS 005
CURRENT IDENTIFICATION Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives
GOODS OR SERVICES KEEP ALL LISTED
EXTENSION SECTION
EXTENSION NUMBER 5
ONGOING EFFORT product or service research or development
ALLOWANCE MAIL DATE 03/12/2019
STATEMENT OF USE NO
PAYMENT SECTION
NUMBER OF CLASSES 1
SUBTOTAL AMOUNT [EXTENSION FEE] 125
TOTAL AMOUNT 125
SIGNATURE SECTION
SIGNATURE /mapjnj/
SIGNATORY'S NAME Matthew Pater
SIGNATORY'S POSITION Attorney of Record
DATE SIGNED 06/15/2021
SIGNATORY'S PHONE NUMBER 732-524-2826
SIGNATURE METHOD Sent to third party for signature
FILING INFORMATION
SUBMIT DATE Tue Jun 15 11:47:39 ET 2021
TEAS STAMP USPTO/ESU-XX.XXX.XXX.XXX-
20210615114739494394-8807
9662-78057f1f88c863980e08
d5396cbc1996af3b19f125278
6170f0eec6c75a1c6ec-DA-47
372537-202106150905006637
64



PTO- 1581
Approved for use through 03/31/2024. OMB 0651-0054
U.S. Patent and Trademark Office; U.S. DEPARTMENT OF COMMERCE
Under the Paperwork Reduction Act of 1995, no persons are required to respond to a collection of information unless it contains a valid OMB control number


SOU Extension Request
(15 U.S.C. Section 1051(d))


To the Commissioner for Trademarks:

MARK: FULGENURA (see, http://uspto.report/TM/88079662/mark.png)
SERIAL NUMBER: 88079662

OWNER AND/OR ENTITY INFORMATION
The owner proposes to amend the following:
Current: JOHNSON & JOHNSON, having an address of
      One Johnson & Johnson Plaza
      New Brunswick, New Jersey 08933
      United States
      Email: XXXX
Proposed: JOHNSON & JOHNSON, having an address of
      One Johnson & Johnson Plaza
      New Brunswick, New Jersey 08933
      United States
      Phone:
      Fax:
      Email: XXXX

The owner requests a six-month extension of time to file the Statement of Use under 37 C.F.R. Section 2.89 in this application.    The Notice of Allowance mailing date was 03/12/2019.

For International Class 005:
Current identification: Human pharmaceutical preparations for the prevention and treatment of viral diseases, auto-immune and inflammatory diseases, cardiovascular and pulmonary diseases, central nervous system diseases, peripheral neurological system diseases, pain, dermatologic diseases, gastro-intestinal diseases, infectious-related diseases, metabolic diseases, oncologic diseases, ophthalmic diseases, respiratory diseases, digital ulcers, and cerebrovascular diseases; vaccines; anxiolytics; anti-allergics; anti-infectives

For a trademark/service mark: The applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all of the goods/services listed in the Notice of Allowance or as subsequently modified for this specific class; for a collective/certification mark: the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with the goods/services/collective membership organization listed in the Notice of Allowance, or as subsequently modified for this specific class.


This is the fifth extension request. The applicant has made the following ongoing efforts to use the mark in commerce on or in connection with each of those goods/services covered by the extension request: product or service research or development

Correspondence Information (current):
      Matthew Pater
      PRIMARY EMAIL FOR CORRESPONDENCE: tmus@its.jnj.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kmanchen@its.jnj.com

Correspondence Information (proposed):
      Matthew Pater
      PRIMARY EMAIL FOR CORRESPONDENCE: tmus@its.jnj.com
      SECONDARY EMAIL ADDRESS(ES) (COURTESY COPIES): kmanchen@its.jnj.com


Requirement for Email and Electronic Filing: I understand that a valid email address must be maintained by the owner/holder and the owner's/holder's attorney, if appointed, and that all official trademark correspondence must be submitted via the Trademark Electronic Application System (TEAS).





A fee payment in the amount of $125 will be submitted with the form, representing payment for 1 class.


Declaration

STATEMENTS: The signatory believes that: the applicant has a continued bona fide intention, and is entitled, to use the mark in commerce on or in connection with all the goods/services under Section 1(b) in the notice of allowance or as subsequently modified, or, if applicable, the applicant has a continued bona fide intention, and is entitled, to exercise legitimate control over the use of the mark in commerce on or in connection with all the goods/services/collective membership organization under Section 1(b) in the notice of allowance or as subsequently modified; and that to the best of the signatory's knowledge and belief, no other persons, except, if applicable, members and concurrent users, have the right to use the mark in commerce, either in the identical form or in such near resemblance as to be likely, when used on or in connection with the goods/services/collective membership organization of such other persons, to cause confusion or mistake, or to deceive.

DECLARATION: The signatory being warned that willful false statements and the like are punishable by fine or imprisonment, or both, under 18 U.S.C. §1001, and that such willful false statements and the like may jeopardize the validity of the application or submission or any resulting registration, declares that all statements made of his/her own knowledge are true and that all statements made on information and belief are believed to be true.


Signature: /mapjnj/      Date Signed: 06/15/2021
Signatory's Name: Matthew Pater
Signatory's Position: Attorney of Record
Signatory's Phone: 732-524-2826
Signature method: Sent to third party for signature

PAYMENT: 88079662
PAYMENT DATE: 06/15/2021

Serial Number: 88079662
Internet Transmission Date: Tue Jun 15 11:47:39 ET 2021
TEAS Stamp: USPTO/ESU-XX.XXX.XXX.XXX-202106151147394
94394-88079662-78057f1f88c863980e08d5396
cbc1996af3b19f1252786170f0eec6c75a1c6ec-
DA-47372537-20210615090500663764



Extension of Time to File SOU [image/jpeg]


uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.

While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.

All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.

© 2024 USPTO.report | Privacy Policy | Resources | RSS Feed of Trademarks | Trademark Filings Twitter Feed